<SEC-DOCUMENT>0001193125-11-290744.txt : 20111101
<SEC-HEADER>0001193125-11-290744.hdr.sgml : 20111101
<ACCEPTANCE-DATETIME>20111101162359
ACCESSION NUMBER:		0001193125-11-290744
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20111101
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20111101
DATE AS OF CHANGE:		20111101

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			STEMCELLS INC
		CENTRAL INDEX KEY:			0000883975
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				943078125
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-19871
		FILM NUMBER:		111171715

	BUSINESS ADDRESS:	
		STREET 1:		3155 PORTER DRIVE
		STREET 2:		.
		CITY:			PALO ALTO
		STATE:			CA
		ZIP:			94304
		BUSINESS PHONE:		6504753100

	MAIL ADDRESS:	
		STREET 1:		3155 PORTER DRIVE
		STREET 2:		.
		CITY:			PALO ALTO
		STATE:			CA
		ZIP:			94304

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CYTOTHERAPEUTICS INC/DE
		DATE OF NAME CHANGE:	19930328
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d249420d8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML><HEAD>
<TITLE>Form 8-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="line-height:0px;margin-top:0px;margin-bottom:0px;border-bottom:0.5pt solid #000000">&nbsp;</P>
<P STYLE="line-height:3px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000">&nbsp;</P> <P STYLE="margin-top:4px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="5"><B>UNITED STATES </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="5"><B>SECURITIES AND EXCHANGE COMMISSION </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="3"><B>WASHINGTON, D.C. 20549 </B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center>
<P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="5"><B>FORM 8-K
</B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center> <P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="4"><B>CURRENT REPORT </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="3"><B>Pursuant to Section&nbsp;13 or 15(d) of the Securities Exchange Act of 1934 </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Date of Report (Date of Earliest Event Reported): November&nbsp;1,&nbsp;2011 </B></FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center> <P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="6"><B>StemCells, Inc. </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>(Exact name of registrant as specified in its charter) </B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center>
<P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="34%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>


<TR>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Delaware</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>000-19871</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>94-3078125</B></FONT></TD></TR>
<TR>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(State or other jurisdiction</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>of incorporation)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(Commission</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>File Number)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(I.R.S. Employer</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>Identification No.)</B></FONT></P></TD></TR>
<TR>
<TD HEIGHT="16" COLSPAN="3"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top" COLSPAN="3" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>7707 Gateway Blvd, Suite 140,</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Newark, California</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>94560</B></FONT></TD></TR>
<TR>
<TD VALIGN="top" COLSPAN="3" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(Address of principal executive offices)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(Zip Code)</B></FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Registrant&#146;s telephone number, including area code: 510.456.4000 </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Not Applicable </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>Former name or former address, if changed since last report </B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center>
<P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Check the appropriate box below
if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </FONT></TD></TR></TABLE>
<P STYLE="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="line-height:0px;margin-top:0px;margin-bottom:0px;border-bottom:0.5pt solid #000000">&nbsp;</P>
<P STYLE="line-height:0px;margin-top:0px;margin-bottom:0px;border-bottom:0.5pt solid #000000">&nbsp;</P> <P STYLE="line-height:3px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Item&nbsp;2.02 Results of Operations and Financial Condition. </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">On November&nbsp;1, 2011, StemCells, Inc. (the &#147;Company&#148;) issued a press release announcing its financial results for the three months ended
September&nbsp;30, 2011. A copy of this press release is attached hereto as Exhibit 99.1. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Company will host a live conference call and
webcast on November&nbsp;1, 2011, at 4:30 PM Eastern Time (1:30 PM Pacific Time), to discuss its financial results and recent business activities. Interested parties are invited to listen to the call over the Internet via the Investors section of
the Company&#146;s website at http://investor.stemcellsinc.com/phoenix.zhtml?c=86230&amp;p=irol-irhome. An archived version of the webcast will be available for replay on the Company&#146;s website beginning approximately two hours following the
conclusion of the live call and continuing for a period of 30 days. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The information set forth in Items 2.02 and 9.01 of this current report
Form 8-K, including the attached exhibit, is being furnished to the SEC and shall not be deemed &#147;filed&#148; for purposes of Section&nbsp;18 of the Securities Exchange Act of 1934, as amended (&#147;Exchange Act&#148;), or otherwise subject to
the liabilities of such section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, whether made before or after the date hereof, regardless of any general incorporation
language in such filing. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Item&nbsp;9.01 Financial Statements and Exhibits. </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">(d) Exhibits </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Exhibit 99.1 Press Release, dated November&nbsp;1, 2011, announcing the
Company&#146;s financial results for the three months ended September&nbsp;30, 2011. </FONT></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>SIGNATURES </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE">


<TR>
<TD WIDTH="46%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="2%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="45%"></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="3"><FONT STYLE="font-family:Times New Roman" SIZE="2">StemCells, Inc.</FONT></TD></TR>


<TR>
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>November&nbsp;1, 2011</I></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>By:</I></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>/s/ Kenneth Stratton</I></FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Name: Kenneth Stratton</I></FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Title: General Counsel</I></FONT></TD></TR>
</TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">Exhibit&nbsp;Index </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD WIDTH="90%"></TD></TR>
<TR>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Exhibit&nbsp;No.</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Description</B></FONT></TD></TR>


<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top" NOWRAP><FONT STYLE="font-family:Times New Roman" SIZE="2">99.1</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Press Release of StemCells, Inc. dated November 1, 2011</FONT></TD></TR>
</TABLE>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d249420dex991.htm
<DESCRIPTION>PRESS RELEASE
<TEXT>
<HTML><HEAD>
<TITLE>Press Release</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Exhibit 99.1 </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px">


<IMG SRC="g249420g76f55.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>NEWS RELEASE </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B><I>FOR IMMEDIATE RELEASE </I></B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="89%"></TD></TR>


<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>CONTACT:</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B>Rodney&nbsp;Young </FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Chief&nbsp;Financial&nbsp;Officer</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(510) 456-4128</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:18px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>STEMCELLS, INC. PROVIDES BUSINESS UPDATE AND REPORTS THIRD QUARTER 2011 FINANCIAL RESULTS
</B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>NEWARK, Calif., November&nbsp;1, 2011</B> &#150; StemCells, Inc. (NASDAQ: STEM), a leading stem cell company
developing and commercializing novel cell-based therapeutics and tools for use in stem cell-based research and drug discovery, today provided a business update and reported financial results for the third quarter ended September&nbsp;30, 2011.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%;padding-bottom:0px;"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#147;As our quarterly results show, we are making real progress in containing our expenses and cash
burn, and I am pleased to report that we are also making significant progress in the clinic with our HuCNS-SC<FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">&reg;</SUP></FONT>
cells,&#148; said Martin McGlynn, President and CEO of StemCells, Inc. &#147;We successfully dosed the first patient in our spinal cord injury trial and are on track to complete dosing of the first patient cohort this year. In our PMD trial, we have
conducted a review of interim data with the clinical investigators at UCSF and are cautiously optimistic that changes we are seeing in patient MRIs are consistent with early development of new myelin in the regions in which the cells were
transplanted. Obviously, we must await the final results of the trial before definitive conclusions can be drawn. I am also pleased to report that there have only been two SAEs in this trial to date, both of which appear unrelated to the cells or
the procedure. We anticipate being able to report final study results in Q2 of next year.&#148; </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Third Quarter and Recent Business
Highlights </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><U>Therapeutic Product Development</U> </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">In September 2011, the first patient in our breakthrough Phase I/II trial in chronic spinal cord injury was successfully transplanted with our
proprietary HuCNS-SC cells. The clinical trial is being conducted at Balgrist University Hospital, University of Zurich, a world leading medical center for spinal cord injury and rehabilitation, and is designed to assess both safety and preliminary
efficacy. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="line-height:3px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000">&nbsp;</P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="51%"></TD>
<TD VALIGN="bottom" WIDTH="41%"></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>USA</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Europe </B></FONT></TD></TR>


<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">7707&nbsp;Gateway&nbsp;Blvd</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Minerva&nbsp;Building&nbsp;250,&nbsp;Babraham&nbsp;Research&nbsp;Campus</FONT></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Newark,&nbsp;CA&nbsp;94560&nbsp;USA</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Cambridge CB22 3AT United Kingdom </FONT></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>T&nbsp;</B>+1&nbsp;(510)&nbsp;456-4000&nbsp;<B></B></FONT><FONT STYLE="font-family:WINGDINGS" SIZE="2" COLOR="#000000">&#159;</FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B></B><B></B><B>&nbsp;F&nbsp;</B>+1&nbsp;(510)&nbsp;456-4001</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>T </B>+44 (0)&nbsp;1223 499160 </FONT><FONT STYLE="font-family:WINGDINGS" SIZE="2" COLOR="#000000">&#159;</FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"> <B>F
</B>+44 (0)&nbsp;1223 499178 </FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">www.stemcellsinc.com </FONT></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">In September 2011, the California Institute of Regenerative Medicine (CIRM) approved our application for a &#147;Disease Team Therapy Development
Planning Award,&#148; making us one of only four companies to be awarded a planning grant. The grant, totaling approximately $100,000, will help fund our plans to develop our HuCNS-SC cells in Alzheimer&#146;s disease by enabling us and our
collaborators to prepare and submit an application for a &#147;Disease Team Therapy Development Research Award.&#148; Each Research Award may be up for to $20 million payable over four years, and the CIRM plans to approve and fund Research Awards in
mid 2012. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><U>Tools and Technologies Programs</U> </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">In July 2011, researchers from the Company and their collaborators published a study in which the Company&#146;s commercially available SC Proven
serum-free cell culture media was used for the reproducible and robust production of large numbers of genetically stable, self-renewing cells that retain true multi-potent biological function over extended culture periods. This work overcomes a key
hurdle to the use of non-immortalized cells for regenerative medicine, and demonstrates the utility of human tissue-derived neural stem cells as a scalable platform for cell-based drug discovery and drug screening applications.
</FONT></P></TD></TR></TABLE> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><U>Other Business Activities </U></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">In July 2011, we relocated our corporate headquarters and U.S.-based research and development operations to Newark, California. The new facilities
comprise newly constructed, custom designed laboratory and office space, and houses the majority of our U.S. workforce. The move also significantly reduces the Company&#146;s annual facility lease and operating expenses.
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">In July 2011, following the affirmative vote of our stockholders at our Annual Meeting, we effected a one-for-ten reverse stock split which reduced the
number of shares outstanding from approximately 139&nbsp;million to approximately 13.9 million. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">In July 2011, we received notification from The NASDAQ Stock Market that we had regained compliance with the minimum bid price requirement needed to
continue listing on the NASDAQ Global Market. The NASDAQ Listing Rules require our stock to evidence a closing bid price of $1.00 per share or more for ten consecutive days. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Third Quarter Financial Results </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">For the third quarter of 2011, the Company
reported a net loss of $4,334,000, or $(0.31) per share, compared with a net loss of $5,552,000, or $(0.44) per share, for the third quarter of 2010. Loss from operations in the third quarter of 2011 was $6,163,000, which was 12% lower when compared
to the $7,001,000 loss from operations in the third quarter of 2010. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total revenue during the third quarter of 2011 was
$224,000, compared to $254,000 in the same period of 2010. Revenue from product sales in the third quarter of 2011 was $182,000, which was a 40% increase compared to the same period of 2010. This growth was driven by both increased unit volumes and
new product launches in the Company&#146;s SC Proven media and reagents business. Revenue from licensing agreements and grants was $41,000, which was a 67% decrease compared to the previous year primarily due to the completion and termination of
several projects funded by grants. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total operating expenses in the third quarter of 2011 were $6,326,000, compared to
$7,218,000 in the third quarter of 2010. In the third quarter of 2011, selling, general and administrative expenses totaled $1,733,000, which was a 14% decrease compared to the same period of 2010, while research and development expenses totaled
$4,524,000, or 13% lower than in the third quarter of 2010. The significant reduction in operating expenses quarter over quarter was primarily attributable to the reduction in force effected in May 2011. </FONT></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Other income in the third quarter of 2011 was $1,829,000, compared to $1,449,000 in the
third quarter of 2010. This increase was primarily due to a decrease in the estimated fair value of warrant liability. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Cash,
cash equivalents and marketable securities at September&nbsp;30, 2011 totaled $12,534,000, compared with $19,899,000 at December&nbsp;31, 2010. For the nine-month period ended September&nbsp;30, 2011, net cash used in operating activities was
$16,846,000, which was 14% lower than the same period in 2010. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Conference Call </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">StemCells will host a live conference call and webcast today, November&nbsp;1, at 4:30 PM Eastern Time (1:30 PM Pacific Time) to discuss
its financial results and recent business activities. Interested parties are invited to listen to the call over the Internet via the Investors section of the Company&#146;s website at
http:<U>//investor.stemcellsinc.com/phoenix.zhtml?c=86230&amp;p=irol-irhome</U>. An archived version of the webcast will be available for replay on the Company&#146;s website beginning approximately two hours following the conclusion of the live
call and continuing for a period of 30 days. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>About StemCells, Inc. </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%;padding-bottom:0px;"><FONT STYLE="font-family:Times New Roman" SIZE="2">StemCells, Inc. is engaged in the research, development, and commercialization of cell-based therapeutics and tools
for use in stem cell-based research and drug discovery. The Company&#146;s lead therapeutic product candidate,
HuCNS-SC<FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">&reg;</SUP></FONT> cells (purified human neural stem cells), is currently in development as a potential treatment for a
broad range of central nervous system disorders. Clinical trials are currently underway in spinal cord injury and in Pelizaeus-Merzbacher disease (PMD), a fatal myelination disorder in children. In addition, the Company plans to file an IND by
year-end 2011 to initiate a clinical trial of HuCNS-SC cells in the dry form of age-related macular degeneration, and is also pursuing preclinical studies of its HuCNS-SC cells in Alzheimer&#146;s disease and stroke. StemCells also markets stem cell
research products, including media and reagents, under the SC Proven<FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">&reg;</SUP></FONT> brand, and is developing stem cell-based
assay platforms for use in pharmaceutical research, drug discovery and drug development. Further information about StemCells is available at <U>http://www.stemcellsinc.com</U>. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Apart from statements of historical fact, the text of this press release constitutes forward-looking statements within the meaning of
the U.S. securities laws, and is subject to the safe harbors created therein. These statements include, but are not limited to, statements regarding the future business operations of StemCells, Inc. (the &#147;Company&#148;); the timing and prospect
associated with beginning to detect potential clinical benefit from the use of the Company&#146;s HuCNS-SC cells; the prospect for continued clinical development of the Company&#146;s HuCNS-SC cells in CNS disorders; the prospect for growth in the
Company&#146;s product sales; the timing and nature of the final data from the Company&#146;s Phase I clinical study in PMD; the timing of patient dosing and possible outcomes of the Company&#146;s Phase&nbsp;I/II clinical study in spinal cord
injury; the Company&#146;s ability to apply for, and possibly secure in 2012, funding from the California Institute of Regenerative Medicine; the adequacy of our existing supply of HuCNS-SC cells to complete our ongoing and planned clinical trials;
and the timing and prospects associated with filing an IND to initiate a clinical trial in age-related macular degeneration. These forward-looking statements speak only as of the date of this news release. The Company does not undertake to update
any of these forward-looking statements to reflect events or circumstances that occur after the date hereof. Such statements reflect management&#146;s current views and are based on certain assumptions that may or may not ultimately prove valid. The
Company&#146;s actual results may vary materially from those contemplated in such forward-looking statements due to risks and uncertainties to which the Company is subject, including uncertainties with respect to the fact that additional trials will
be required to confirm the safety and demonstrate the efficacy of the Company&#146;s HuCNS-SC cells for the treatment of spinal cord injury, PMD or any other condition; uncertainties about whether myelination formed by donor cells, if any, will have
any biologic effect; uncertainties about whether preliminary data in any Phase&nbsp;I clinical study will prove to be reproducible or biologically meaningful in any future clinical study; risks whether the FDA or other applicable regulatory agencies
will permit the Company to continue clinical testing in spinal cord injury, PMD or in future clinical trials of proposed therapies for other </I></FONT></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>
diseases or conditions such as age-related macular degeneration; uncertainties about the design of future clinical trials and whether the Company will receive the necessary support of a clinical
trial site and its institutional review board to pursue future clinical trials in spinal cord injury, PMD, age-related macular degeneration, or in proposed therapies for other diseases or conditions; uncertainties regarding the potential for the
Company to grow its SC Proven business and to advance the development and commercialization of stem cell-based assays for drug discovery and development; uncertainties regarding the Company&#146;s ability to obtain the increased capital resources
needed to continue its current and planned research and development operations, including such operations of the Company for non-therapeutic applications, and to conduct the research, preclinical development and clinical trials necessary for
regulatory approvals; uncertainties about the Company&#146;s ability to secure funding from any governmental agency, such as the California Institute of Regenerative Medicine; uncertainty as to whether HuCNS-SC cells and any products that may be
generated in the future in the Company&#146;s cell-based programs will prove safe and clinically effective and not cause tumors or other adverse side effects; uncertainties regarding whether results in preclinical research in animals will be
indicative of future clinical results in humans; uncertainties regarding the Company&#146;s manufacturing capabilities given its increasing preclinical and clinical commitments; uncertainties regarding the validity and enforceability of the
Company&#146;s patents; uncertainties as to whether the Company will become profitable; and other factors that are described under the heading &#147;Risk Factors&#148; disclosed in Part I, Item&nbsp;1A in the Company&#146;s Annual Report on Form
10-K for the year ended December&nbsp;31, 2010 and in its subsequent reports on Form 10-Q and Form 8-K. </I></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#150; more &#150;
</FONT></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">StemCells, Inc. </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Unaudited Condensed Consolidated Statements of Operations </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">(in thousands, except share and
per share amounts) </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="62%"></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Three months ended<BR>September&nbsp;30</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Nine months ended<BR>September&nbsp;30</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2011</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2010</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2011</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2010</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Revenue:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Revenue from licensing agreements and grants</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">41</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">124</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">163</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">409</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Revenue from product sales</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">182</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">130</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">516</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">319</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total revenue</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">223</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">254</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">679</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">728</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Cost of product sales</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">60</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">36</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">167</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">105</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Gross profit</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">163</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">218</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">512</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">623</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Operating expenses:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Research and development</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4,524</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5,201</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">15,104</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">15,096</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Selling, general and administrative</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,733</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,018</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5,912</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6,889</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Wind-down expenses</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">69</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">259</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">291</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total operating expenses</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6,326</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">7,219</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">21,275</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">22,276</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Loss from operations</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(6,163</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(7,001</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(20,763</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(21,653</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Other income (expense):</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Realized gain on sale of marketable securities</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">84</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Change in fair value of warrant liability</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,697</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,228</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5,184</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Interest income (expense), net</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(13</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(11</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(45</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(48</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Other income, net</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">145</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">232</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">107</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">230</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total other income (expense), net</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,829</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,449</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6,646</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5,366</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Net loss</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(4,334</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(5,552</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(14,117</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(16,287</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Basic and diluted net loss per share</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(0.31</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(0.44</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1.02</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1.33</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Shares used to compute basic and dilutedloss per share*</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">14,009,341</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">12,709,172</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">13,831,749</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">12,201,532</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Adjusted for 1 for 10 reverse stock split </FONT></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2">&#150; more &#150; </FONT></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">StemCells, Inc. </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Unaudited Condensed Consolidated Balance Sheets </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">(in thousands) </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="74%"></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD ROWSPAN="2" VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>September&nbsp;30,&nbsp;2011</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>December&nbsp;31,&nbsp;2010</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(unaudited)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(unaudited)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>ASSETS:</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Current Assets:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Cash&nbsp;&amp; cash equivalents</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">7,294</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">19,708</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Marketable securities</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5,240</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">191</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Other current assets</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,090</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,270</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total current assets</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">13,624</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">21,169</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Property, plant and equipment, net</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,248</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,627</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Goodwill and other intangible assets, net</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4,674</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4,874</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Other assets, non-current</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,914</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,932</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total assets</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">22,460</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">30,602</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>LIABILITIES AND STOCKHOLDERS&#146; EQUITY:</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Current liabilities</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5,467</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5,528</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Fair value of warrant liability</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">172</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6,672</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Other non-current liabilities</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,846</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,921</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Stockholders&#146; equity</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">13,975</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">15,481</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total liabilities and stockholders&#146; equity</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">22,460</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">30,602</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">#&nbsp;&nbsp;#&nbsp;&nbsp;#&nbsp;&nbsp;# </FONT></P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g249420g76f55.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g249420g76f55.jpg
M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````9```_^X`#D%D
M;V)E`&3``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$"
M`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#_\``$0@`4@%-`P$1``(1`0,1`?_$`.(``0`!!0$``P$`````
M```````(!08'"0H$`0(#"P$!``$%`0$!``````````````8#!`4'"`(!"1``
M``8"`0,"`@0'"@<-"0```0(#!`4&!P@`$1()(1,4%3$B%@I!43(C,Q<Y84(D
M-#6VEUAX&7%28]2W&!J!P6)R<[-5==4V=E?7LE,EE4:6UG=($0`"`0,#`00%
M!@<)"PL%```!`@,`$002!08A,2(3!T%187$(@9&A,B,4L=%"<I(S%<%28I/3
M5187-_"BLD.S5'2T=388X8+24V-SHR0TE#7Q@V0EE?_:``P#`0`"$0,1`#\`
M[^.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*5#[+>\VON)'CJ&=V
M5>XV1F<Z3F!HS=.;5:+D]!0?RIG#6"9JD,':=,SD5B"`@).O--<O\^/+OB$S
MX4V4V;N:$AHL51*5(]#R76)2/2"^H>E:AV[\[X]M#F%Y3-DCM2(:K>]KA![M
M5_9437WEAK8+B6)PO.NVQ3]!5?7**9+B3_&%!I#R:9#=/P"H/^'FHI_BXVS6
M1B;).\8]+Y,:FWN6-P/TJB,GFWBW^QPG*^V10?F"M^&KWIWE+P[,NDVUNIET
MIQ%#%(>0;#'6F/;F,(`)G`1RK64!(O7J(D:J&Z!^3S.[+\5O#<V81;Q@YV&I
M_+71.@]IT%7M[D)]E7V'YJ;-,X7,@FA!](TR`>^UF^936P&B9.Q_DVO_`&IH
M=MA+-!%`1</HYX0WP)@(*AD9-LK[3N*<$3*)C)N4TC@7U$.G.AM@Y3QWE.W?
MM7C^9!E8`[61AW/39U-FC-NI5PIMUM6PL#=-NW3'^];?,DL'I(/9^<.U3["`
M:B[E/R`Z\XT=NHEI-R&0IQH<Z2[*BMD9*/;KIF[3).+$[<LH,PE$!Z^PLX$H
MAT$.O-5<L^(?RYXQ*^)#/)N6<A(*XJAT!'H,S,L7Z#/;TU%=U\PN.[8YA1VR
M)QVB(!@"/07)"_,3497/EB@/?_@&%9I=H!AZK.;K&MU^T/H-[+>#>)%$?Q"I
M_N\U?)\7.W>)_P"7V29H?6V4@:WN$3#^^J,-YMX^KN83E/695'X$/X:R;1O*
M!A"Q.DFENKUQH?O'*G\Q6;M+)#H&$>AA<KPBII-),O7U,#,P=/IZ<E&P_%/P
M7<I1#O&-FX`)`UD+/&/SC$=8'_VS64P?-+8\APF9'-CW_*(#J/?I[W][5]9%
M\BNNE($6T)+2^1Y#VB*^U38\#1J7>4IRD<3<PK&1X'`I@[BI"L8@^A@`0$.9
M_DGQ(^6^Q'P\&6?<\BP-L9+H+]>LLA1/>%U$=A`-7^Y>8_&\'NP.^3);_%CN
M_*S%1\U[>FK$J/D;A;BX3!CBN4:M#FZ`LYM;`RX%Z^@F2;Q"J)3?C#W!_P`/
M([LWQ+8.]2#[OM,J1$]K9"7^81D?WU8_#\R8<QAX>(X3VR"_T+^[4RJ)F:"N
MZ:0ECI"*65`!`BYD'2/4?P>\W-W?3^,@<W9L'-L#?5!6*2%SZ[,/G'XJFF!O
M6/G`65D8^NQ_!^*LP@/4`$/H'U#DS[:S-.*4XI3BE.*4XI3BE.*4XI3BE.*4
MXI3BE.*4XI3BE46QV2NTZ!EK3;9V'K%9@6+B4G+#89-E#0<-&M$Q5=2$K*R*
MS=C'LFZ8"8ZJJA"%#Z1Y6Q\;(S)TQ<2-Y<F1@JHBEF8GL"J`22?4!5'(R(,2
M%LG*=(\=`2S,0JJ!VEF-@`/636INU^>'Q95*=5@%]G&4\NW7,W<251H&2K17
MTE"*>T<4IZ(J+B+?H@("(*M5%TC%#J4PATYMC$\B?-+,QQD+MC(I%P))84?]
M%I`P/L8`UK/+\Y_+G#R#CR;AJ<=I2*9U_26,@^\$CU5.W6O;W6O<"M2]MUMR
M]5LK0U>=LX^QC`G?-I2N/I!%9PP:S\#,LHR<AE7R+94R'Q#9,%@2.)!,!3=(
M)R3B/).(Y*8G(\27%FD!*:K%7`(!*.I96M<7L3:XOVU--AY/L/)\=LK8LF/(
MB2VK3<%=5[:E8*PO8VN.MC;L-63D#R%Z-8IN=AQUDK:[!5&O=3>EC;+4K-D.
MOQ,]!OSMD'A6DG'.W:;AHN9JZ34`I@`>PX#^'E[M_E]SC=L./<=LVK.GP91=
M)$A=E87(N"!8BX(JSSN<</VS*?!W#<L.',C-F1Y%#*?403TJSO[TWQQ?UV=;
M?Z5*O_GW+W^JWS&_F3<OXA_Q5:?UC\#_`)WP/XY?QT_O3?'%_7:UM_I4J_\`
MGW']5OF-_,FY?Q#_`(J?UC\#_G?`_CE_'4SZ1>*?DJH5R_X_LD/<:3;XEI/5
M>TU]\A)PD]#/TP692<7(-C'0>,G21@,10@B4P#U#D,S<++VW+DP,^-X<V%RK
MHX*LK#H58'J"#VBI;B9>-GXR9F%(LN+(H9'4W5E/80?2#44LH^1[0["UODJ!
ME#;+!]0NL*J=O-5A_>8IQ,0KM,W:HRF6<<J]5B7Z1ORD''MK%_"4.2K:_+KG
M6\XBY^V;3G383BZN(F"L/6I-M0]HN/;4;W#G7#MKRFPL_<L2/+0V9"X+*?4P
M%])]AL:QW_>[>,W^NK@C_P"["_YMS(?U2>97\RY_\7_RU9_UE\#_`)UQ/TC^
M*ITX^R!2LK4FL9(QS98NXT6Z0[2?JMIA%_BHF=A7Y/<9R4>X[2^\U<)^I3=`
MZAR#9^!F;7FR[=N,;0YT+E'1A9E8=H(]8J7X>9B[ABQYN$ZR8DJZE9>Q@?2*
MQ5L/MCKAJ;`0=GV-S#3,1PMFDUH>N.+6_42<3LBV1(Y>-XB-9(/)21^!;J$.
MX.DB=-N4Y!4,4#EZY7C_`!7D7*\A\7CN'-ES1KJ<(.B@]`68D*+F]@3<V-KV
M-8[>^1['QR%)][R8\:.0D+J)NQ%KV`!)M<7(%A<7[165Z!D"D94IE;R+C:UP
M5XHEPBV\U5[969)M+04Y%N@'V7D?(-#J(+IB8IBF`![B*%,0P`8H@&*S\#-V
MO,DV_<8G@SH6*NC@JRL/00>H_='4=*R.%FXFXXJ9V#(DN)*NI74@JP]8(^8^
MH]#UJK6*Q0-1@)JU6F9BZY6:W%/YRP6";?-HR'A(6*:JOI.5E9%XHBT81[!F
M@=5994Y2)IE$QA``Y2Q\>?+G3%Q4:3)D<*B*"S,S&RJH'4DDV`'4FO>1D08L
M#Y.2ZQX\:EF9B`JJHN68GH``+DGLJ/6N^Z.JNV2UI;:XYTH.7'E*,T"TL*K)
MJ*R,,B_.LDQ?.(YZW9OCQ;U5NH1)VFF=JH<@E*H(ATY(.0\-Y3Q01-R+!GQ%
MFOH+KT:UK@$$C4+BZDAA?LK#;+RGCW(VD39,N+(>+ZX4FZWN`;$`Z218,`03
MZ:D]R,UGZTT;9;17[,.0AUHUT._<HN))6NV&9KZXHR%JED^\DI$1\HD<I8VI
MPY"'!^[[B%6]M3J<$"#[O%/F]YJ\AYER+^K#RW,C1O*899(39\B07$D:2`C1
MCQB_BR7&JS7(C'?TOR[E.X;SN']&>-ZB"VAV0]9&'UE##ZL:]=;=+V/72.N8
ML1:"X/PQ5E+WG^4@+1)1#`\M8'UGD6\+B^I-T2@JX54+(+,6CMLS#K[CN2/[
M)OI!)/FQ?+CX9>-[2D,G)(OVOR)[6B`8XZL>Q8X@-4Q]&J0$-Z(UJ0<>\MMK
MP$67=0,K-(^J?U2GU!?R_>U[_O16%;?YG/$7B!^:J1^8:9-_`K'8KDQ/BNRV
MNO-#('%$Q4YJMU,]=>H%$OH=JX7((>H"/.U-E^''E[88^X;#C8F+I&E67'@-
MK=/LR0P]S*#6R(-CBB0)#CQ(GJ"J/H`K+F*]B?%SY!C+5?&=XPW?[>HU.J%<
M*Q6QYE9N3VSG4<QL5,1]6N3LK0I1,=1J1=`G3ZX]/IUKYB_#EC)BD\WXW&D!
MZ#(2-05)Z"V3CFZF_4!G%_4:Q.Z<4VC/C*Y^)$;_`)04*P]SK8CYZCME_P`?
M>7*!:$6.`IR;GZ)D-P6N3*"LP>(?P#%8_P`5[%X69"V:SE51*@)@<@B8X'*"
M9T1.<AE.%N9?#OS#CVZB#R]GGR=BW)O!D!D,;Q(3JME%=*RP"U]>F]QI9+E2
MVH-X\O-WV_*"<?=Y,').AAJTE!VVE(L&CZ?6M?T%>HO,#%6B6O>#:T>VY95@
MKG*0[#YE8;1?%V<=0J\FW3!1TLVBY%9*&9QC3UZN)`RQ^T.X13Z]H;S\OOAN
MX=Q](1ND'[9Y`UA]HA:(.?R8<<7!%^@+AW/L[!-MA\N]EVQ%;-09>;87+BZ`
M^I4[+>UKGW=E8FLWEP\2>-9)Q5'.R.&C+,%C,G"%&J-@N,&W.D/MF(27HU.F
MJ\JD0?3JDX.4.G.MMM\@N9S8BG!XZ(L4CHK1P0]/^[<HP^514^CVA$31'CQJ
MGJ"J/HZ5D&A7#QJ^0-A*-</W3"^3IQFS4=/AQ^^:5?)L(T*HD@,J[A0;PMO;
MLDG#@A/=>,SM1.<I3`(B`<U/YC?#KM#1>'S;COW.63NKD)$(6U=3W<B'NLW:
M=+,P])4BL'NW#]EW%"N=B(KGL=0$<>YEM?Y;CV5]3ZR:7:;42;S!G>;A%*O7
M7C+YID#,;EH>M5\DQ,-XB#;#%I-DX-)1P_?MVP*JH*J*+G`0$@&[0UYY=_#)
MP_#W!</!P9=\WZ1F*#("RV"ZGLD(`B[JBY9E9C8FXO:L-LWEYL&W-J:,Y>3<
MD&6S`>JR6"]!Z2"?3T[*E-@++>MNPE'5NVNEIQQD>@,9I[6%9RAH1SB#;3D8
MW9N7T0)F[1!(CIHWD$#'(!?0JI?Q\W5NG"Y>)Y`VK=-M3!R/##B)HD3N&X4A
M0+6-B![JF/W&#'`C$2(MNP*`/F`K,!JK715!PE$,6CDH@(.&39)HMZ#U^L9`
MA`4#_C`/,,=HVW7XJ0QI*/2H"GZ+7^6O!Q,;5J"*&]8%OP5Y+O=JEC.FV6_W
MVP1M5I5+@Y"Q6FRS"X-HN"@HEL=W)2D@XZ&!%HS;)&.H;H/0H#S-8.%E;AE1
M;?@QM+F2N$1%%V9F-@H'K)JY52Q"J+D]E8FP%M?K?M,SL[_7?,E'R^RICJ+9
M6IS2I4)1*"=S2#MS%-Y`P)I^RH_;L5CIAZ]Q4Q_%S+;]Q;D7&'BCY!ASXCS!
MB@D73J"D!B/78D7]]>GCDC^N"+U(3F`KQ3BE0ZV9\@&G6GJ[..V(SS3,?V&1
M:?'QU/,I(6*[O6(]WMO4Z=5F,U8TF"YB"5-RJV3;G,`@!Q$!Y+N-\#Y=RY6D
MX_@S9&.IL9+!(P?5XCE4N/2`2?956.&67Z@N*C7C/S:^,K*EBCJI![-P4%.3
M$@TBXEO?*M>*(QD'[Y4C=HV2G+/6XZ!14<.%"ID!9TEW',`!U$0Y)-R\E_,K
M:\=LJ?;)'@12S&)XY2`.I.E'+&PZ]`:J-AY"BY6X]G6MK/-6U;4XI3BE.*4X
MI3BE.*4XI3BE.*5R)?>GLYY%@8+637R%DY&*QM?D;_D.[LV2R[9M<I>F/*O&
M5>&E#)F(1[&P)YIP\%L?N2,Y5;JF+W(IB'6_PM;'MV1D;GR"95?<L?PHHR;$
MQK('9V7U%](6XZV##L8UR_\`$?O6?CP[=LL#E,&?Q))+7&LH5"@V/4)<FQZ7
M8'M`J26@?@V\9V3=/<)9,N-;DL^VO*N-*M<K'D(F3+I"LF5@GHAL^G*]7(BE
M6*$BX5"J2JRT>9)PFL^(LV.#@_N`8A8WSWSQ\S-MY?F[;B2K@8N+DO&D7@QL
M2BL0KNTB,S&10'N"%LPTBW4Y[A/DYY>[AQ7#S\N-LW)R<='>3Q9%`9A=D41L
MH&AB5[P+7'>/H&WO1SQ^8!\?-1R'2,`HVH(3(]Z^W4LK<YI&Q3#59*$C81A`
MM98C!@X7@HE)BHHV*X]YP0[I7O5/U`>:BYOS_?\`S`S,?.W\Q>-C0>$OAJ44
M]XL6*W(#-<!K6%E%@*VGQ#A.R\)QI\391)X,\WB'60Q'="A00!W18D7N;L;D
MU##8SP(:-;0YOR/L!DN4SNC>\HSB5@LJ59R)#1,"F^1BX^((6+CG%+D5FC?X
M2-3ZE,NH/?U'KT'H$SXWY\\XXMLF/L&VK@G!QD*IKB=FL6+=2)5!-R?0*BF_
M^3'$.1[M-O6X-E_?)VU-I=`M[`=`8F/H])-<E?F1T-P;H9MEBS">#W%Z=4ZY
M8HJEUF%;W865BF@F)K(%NK+PK)^SA85)NR"-A$.Q,43B57N-W"`@4.L_)WGF
M^\[XEE;WO8@&9#ER1KX2E%TK%&XN"S$G4YN;]EA:N7_-?A6S<-Y1C[1M'C'$
MDQ4D;Q&4MJ:2538JB@"R#T'K?KZNF5'[LQXXE$DE!F-E`%1,AQ#]:E?]!,4#
M?^7O[O.:#\3'F,#;1MO\2_\`+5T./A]X&1?5G?QD?\C4Y]L8@^B'BDS16=?I
MF>A_]7S6*:JF,K#,/TY"SQ"49"E@(J96E&S6/36GHU%U[Z2Y$4@*X(4P%#IT
MY!>)RCG7FIA9&_I&_P"T-S629%%D:[:V722>Z;6()/0D7J:<DA_HAY<Y6-LK
MNGW/`*1,2"Z]-(:X`&H7N"`+&W2N1?PU^(_&ODJKN<\AYBRQD*H1N.;5`5>/
MC:*2#/.3TY8(MU896>GYZSQTZ0Z1$S)D(F1`5EEE%%%%0Z%*;KCSC\VMR\M<
MG!VW9L3'E?(B9R9=6E50A%550K[3>]@``!7+GE5Y88'F'CYFY;QE3QK%(J@1
MZ=1+!B26<,+=!8!?E%NN[+_9:]-?_/G9;_YEC3_T^YI;_BCYE_F&V_--_*UM
MK_AOXE_GNX?/#_)5T!:XX.KNM&",4X!J,K,SE9Q'2H:CP<O8CLE)R1CH1N#9
MNZE3QS1BQ,]5('4XI(IDZ_04.<_\BWO)Y)ON5OV8J)E9<S2,J7T@L;D+<DV]
MY)K>6Q;1!L&SXVS8S,\&-$L:LUM1"^DV`%_<`*X]/O3.159[9+5_#[)P=W]B
M\0V:Z+QK?O543E<D7%.$:![!`,8SE=G0`[``!,8#@`?3SL#X6]N$''-TWB06
M$V6D88_O88]1Z^H&7K7*OQ(YXGWW;]I0DO%C,]AZY7*]GK^R%;"/NQ.RXW[5
MK)^LTV^*I/:^WL9^L-EE1^(''65%'TPD@@B;ZPHQ%XCY;O$/0@/$B]`].NO?
MB;XR-OY3C<E@7_R^X0:7/H\:"RWO_"B,=OS34[^'?D/W_C61L,I^VPIM2C_L
MY;FWR2!R?SQ4@?O%NRX8.\?\QC.)??"VW9NUQF+&94SB1RG2X\2VO(CPG:8H
MBW7B(Q&+6Z]0$LJ`#]/(_P##OQG]N\_3<9EOA[9$TY]7B'[.(>\,QD'MCK.>
M>W(3LO"'P83;*SY!$+=N@=^0^XV5#['KGX^[19$5I/D0G:&Z(=$F6L"7JO`@
ML!T3A)U25K5[9'%(X%-WEBX9[T]`'M.(_1SH'XEMN&;Y?1YZFYQ,^)[C]ZZO
M$>OYS+\HK1OP]9[X?-WP7Z+D8<BV/[Y2D@/Z,;?/7;!MWDYWB37W(-LBEQ;3
MRT<C7*\N41*HWF+*Y2AV[Q$P"`E6CD72CDHA]`H\_+CSBY3-P_R[W'=\1M.X
M-&(83Z1).PC##VH&+CVK76O,-T?9^/9&7$;9!4(A]3.=((]HN3\E0_\`&3AV
M-@J#/9PFFZ9IRU/'\%7WSSM[HVIP:P)2;E)=0>B9IF;05]XX]!%-H3UZ";KI
MWX6N$P8FPS\WR4U;CF2-#`2+E((S9RI]<LH(8]I$:^LU$/*_98X<!][E6^1,
MQ1"?1&IL;?G/>_L45S#[M;2;+^:S=MOI]K(_>(X"A;5+1%*KPOGL33YR,J*Y
MV]HS[EQPT(91]"HF2.K%-54U0;-E&Z3=$S]T83_LMPOC/&_)GA1Y=R50=_>)
M6D:P:16D%TQ8`>QO1(P(N0Q9A&O3=T4<>)#XLGU_[N@K=#A;[M-H[3JDP:YG
ML66,TWD[0`F9UO;G6.:R1Z<@>Y]GJQ5>QXS:H'Z@G\9(/E#``"8?40YIW>?B
M/YOF93-LT>+A85^ZIC$SV_AN_0D^G2BBK5]PF+=RP7W7J).U'W:1U"V*FW?0
M/-$S5)-I:X3YA7LN61X1[26YWB8*WND9(JT8VL97=;$0<#'K('=+$(/LO`4`
M$SROC'Q(+-C387/,))HC$UG@06D-OU4D+L4L_9K!"B_5+=14BW#I:<7%O1^*
MNH3#-5N&*<+42I9:RN\RY<:/364?=<O6&*C:T\M[R):F%]99:.CSF8L#"W3_
M`#AQ.<YP3]U8YU#'./,N\96)NF\SY>U8HQ,.>8F.!6+B,,>B*3U/7LZ`"]@`
M+"L>Y#.2HL">RN(W9#8+:WSN;L+ZQZ^33R`UNK\S++5B$7=OX^BQ]`K$@2-D
M<\9>38""E@D)=9=,\5'J`H"`NF[1L0%SKN#=I<<V#BWD;PL<FY`BR<DD10[6
M!D,KBXQ<>_U0MOM'%KZ69CI"J,M&D6'#XDGZP_/?U"MU>,ONT6AE8JC*-R79
M,V94N'P@)RMH)=@H48H\$/KK0E7K+/VHMJ0?T:3EW('``^LH;UYIK<OB0YUD
MY32;;'A8N'?NIX?BFWJ9W/>/K(5/<*M&W"8FZ@`?/4_-"O%AK1X\)K*=BPN-
MOL$_D]>,:J6'(C^)G;#6:C%)$50I4'*Q\-#G+"N)DRKYP90@KN511!4QP;I=
M('SKS/Y)Y@Q8L&\^#'!C`G1$&5'D;MD92S=[391;H!>P&HU0FR))P`_8*PQY
M]/V6&QG_`%AB#_3)0^9GR(_M0V[\W(_U>6JF%_ZE?E_`:CK]V>_9Z6C^TMDS
M^;./>2#XD?[0(_\`9L/^'+53</UX_-'[M=#/-`585!_R7?L^=S?[-^6?YH2?
M)IY<_P"_NS_[1@_RBU6Q_P!>GYP_#6A/[JO_`-P-TO\`QQA7^;%YYO7XH?\`
MY#9O^XR/\..KW<OK)[C^Y769SE:L95IWVP.ZE1;I:F#`TJ^K-3L=@9Q9`,8\
MD[AH=Y)-V!`)]<3/%FP)@`>O4WIRZP<=,O-AQ9&TI+*B$^H,P!/R7O7U1=@/
M6:_GU^*S!&-?*5OSD)]NO?YV=E++5K+F-U`ELRU?F\LV\U@B$#U)M,IK)2K2
MOU>$DU5P81JB+A-@T(FB*3=%40[X\T=\W+ROX)CQ\+QXXXHY4QPVC6L":&/B
M%;%2[LH&MP068DW9A6;R7;&@'A`6!M[JZH5O`9XWV5ZQQD*E8SM^/YK&]XJ=
MX:,(/(UKF:[97-3G&$XWA[5"7=_:D'D2^78%(N#8S1<2F'HH'T<Y?'GMYBO@
MY.!F9,,\.3`\9+0QJZ!U*ED:,1D,`>E]0]E8[[[/8AB""+=GXJW/\T[5I3BE
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M6!-NJ,`-0#7`*]>@_*SS,CY]A209<:P[YC*#(JWT.IZ:T!)(L>C*2;74W[UA
MNFYIBMLUPG?>9/VB.`?[/6/O],.1>=T?#3_9WG_[0F_U>&N,_B#_`-^\/_0(
MO\M/7=4U_BK;_D$?^;+SAAOK'WUV6OU1[JUS^7O]F5NI_P#HRS_^VSYL;RA_
MM,V7_3D_`:@_F9_N%NG^BG\(KB'\;&4O+5CZD9.:>..K76P4J2MT0YR4O5<8
M4"^MV]L1A`1BD73NY1<@YCUS0H@8$D!*F8O0Q@Z\[9\RMK\IMPSL9_,66%,U
M86$(>>6(F/5WB!&R@][TGK7'OEWN'F=AX,Z\%25L,R#Q-,,<@U6-NKQN1TOT
M%JWHZ/YX^\$V;;/!<#M-1<G1FO<G<C-\JOYC!V)*W%M:W\DEU2J/IV"@6LO&
M(_-$VX>X@H0_40#KT$0YHOF^Q>0&-Q/.GXM-C-R!8;P!<J=V+ZE[%9RK&U^A
M!%;HX?N_G9D<EQ(N21SC9&D^U)QXD&FQ[66)2/D(KK&YRG72=<,NW8MMI?O)
MF.L?J$^=5VC9HU_IKMD8`<-S0^)ZQ#Y.N3!0@E,7X;YHG(IKE$.GJ8!YW%Q+
M5Q?X;LG<`=&1D865(#V'5.[0QGWZ2EODKCOE`7DGG[CX+=Z"'*QUMZUA5))!
M[KB2_P`M5#5=13Q@?>!+K@YT<\'B7.-SG<=Q2)U2D8#2LY&;W["ZA3"9-N8L
M!<Q80XJC^B`'`>@]W*7*0OF=Y`0;VGVF[8,*S-Z_$QKQ9'3M[\>N2WI[M>^-
MW\N_.R;:&[FUYDK1+?HNB>SP6]!TN8U)]%FKW>9";E/(/YAL!:+T^06=5G'+
MZF8JESL%%7"$;.7QPQOV9K$"9?J%<5K'[=HDN)?R%(PY1'J`\I^3L,7E]Y0;
MASG,4#)R%DG6_34L0,6.GN>741['%5/-6:3F_FG@\.Q3>"!DB-OR6<B29Q^:
MEM0_[(U9^082.TO^\ET$L`T0K=+LN9L5(Q#-E_!F+6JYUQI&8^>-TRAVE!DT
MF9QP4Q?7]"/TCR]V^>3F?PW9'CDRYL6'.6)ZDOC3-*#[RJ+U]M6>=#%Q/S\@
M\("/#?*A5`.@"Y$:QGY`9&'R5U*>3T5PUVB/;Z^R.3ZP#KIUZ"3Y58Q2`>GI
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MC\P<B*%$,AA$F2V.&)TZR`&4.1W1?KIO[:S>0N.UO'('JZVK:6;=S[RZ!1[<
M)YL$?3_^+Z]^/U_^C?Q<U@.%?#=_GN'_`/T7_E*MA%M_I(_2KM1JCB5=U>MN
MIU-1*;<P$.XF4ED`:JIRJT<V4D$U6Q2D!LH1V8X&3```@ATZ>G.-<E8ER9%@
M-X0[!>M^[<VZ^GIZ:Q)M<V[+UJ/\^?[+#8S_`*PQ#_IDH?-L>1']J&W?FY'^
MKRU=87_J5^7\!J.OW9[]GI:/[2V3/YLX]Y(/B1_M`C_V;#_ARU4W#]>/S1^[
M70SS0%6%0?\`)=^SYW-_LWY9_FA)\FGES_O[L_\`M&#_`"BU6Q_UZ?G"M"?W
M5?\`[@;I?^.,*_S8O/-Z_%#_`/(;-_W&1_AQU>[E]9/<?W*ZS.<K5C*^IBE.
M4Q#E*<ARB4Q3`!BF*8.ABF*/4!*(#T$!X[.H[:5R"[\_=X<HL,H3F?\`QXVR
M/8?,+$\NJ6&92RKT.RT:RNW2D@NKA[("!F[%",!ZJ<S1B_7CU8\I@32>*)@4
MA.M>"?$%MC[6FP>8,+,%C$?WA4$J2H!8?>(C<EK6U,H8/VE`>IRD&<NCPYQZ
M.WM^<5'#6;S5[Z:&9E98`\B5>N=[I4/(1\;<4,DPI([.="A'JGMHW"OVEL1%
MKDR!01ZN`!V+T9%!,P-GY3^AI'R7R:X+SK9VW_R\DA@S'4F/P6OC2L.V-T-S
M"Y[.FG03WHR.RI)B0S)XD%@?9V'\5=NL#.P]H@H6S5Z0;2\!8HF.G8.69']U
MG)P\NS1D(R0:*=`]QL]9."*)F_"4P#SBR>";&F?&R%*3QL593VAE-B#[000:
MQ!!!L>VJMRE7RG%*<4IQ2G%*<4IQ2G%*<4K5UOIY9-=_'?DW#./,WPEYEDLN
M0%ML2\S0V47..J1&5U]$1D;(3E==R,9(O8VQ2#]RDFHT,JJF+%3\TI^#9_`_
M*CD7F'MN;N&R/`AQ'C0+*642EPQ8*X5@&0!20U@=0ZBM=<T\R]CX+N&)A;ND
MS+E([%H])\,*0%+*64D.=5B#<:3T-0TV+^\*>-U#!E\2H5ILV:KA:*58H*'Q
M>3&=R@V\F_FX5W'(QUOE+C!P\!'U]11UV/C$5=J"@)P325'H49EQWX?/,AM\
M@^_PQX6'%,C-/XT;%0K`DQK&S.7Z=VX47M<CMJ);]YY\`_8TXPI9,O*DA=5B
M\*102RE;.755T]>]8L;7L#6KO[K;KUD-3+F=MHW<2]C,5LL:CAF"F%T%F["V
M7&9M5=M$PV@U%"@20:U&.K*97:A!$J2S])/J)P4`NS_BBY%MW[)P.+QNK[H<
MG[PR@W,<:HZ+J]1D+G3ZPC'U5KOX<]AS_P!J9G))%9=O\`PJ2+:W=T<V]>@)
MWOSE]==JG.+ZZVKA.^\R?M$<`_V>L??Z8<B\[H^&G^SO/_VA-_J\-<9_$'_O
MWA_Z!%_EIZ[JFO\`%6W_`""/_-EYPPWUC[Z[+7ZH]U02\HU)L^1?'AN)3J9$
M.IZS2^";N:*AF)!5?22L;'_-EVC)`H"=R\5:,%/:2*`G54Z$*`F$`Y._*_.Q
M=M\PMGS,UQ'C)G1ZF/0#4=()/H%R+GL`ZU#O,+%R,SA&YX^*I><XCD*.I.GO
M$`>DV!L.TGI7(IX+O*OK5H!2L]4+85I?VK;(]LJMUJMCI=;"UM3GC(->"DH6
M5CT7K1^P<$`J*Z"Q2JI*E.H4PIF(7W.M_/+RKY+S_-P-PX\<=CCQ/&Z2/H/>
M8,K*;$$=H(Z$="+WZ<O>37F3L'"</,V[?1,IED5U9%##H""I%Q;M!!%P>M[=
M+[[/]I+\9W_3F;_Z'Y3_`+3YH?\`X;O,O]YA?^X'_1K=7]?GE_\`]9E?Q0_Z
M=;G,'9FI6PN'\=9RQVK)JT3*%4B[G5EIN//$2IX270^(9GD(U510[%R*?Y29
MC")?Q\TSO>SYO']WR-DW$*,[%E:-])U+J4V-CZ1[:VQM.Z8N];9#NV$6^Z9$
M8=-0L=)[+BYM\]<8/A[%;9WSKY_V",0CN.KS_:#+:#CI[R*:-HM?ZN:P"2G0
M0`?E-O$4A_Q4AZ?1SLOS?MQGR+V[CXNLDBX6.1Z;I'XSG]*/K[ZY-\K+\A\Y
M,[>F[R1ME3J?19V,:CWVF%O=4HOO/6`92MS&KN\%(15CYJLS1<1VN=8I^VX8
M24<^<Y%Q)+JN$Q`P*L91G,I$.8.H&.B7K]`<C'PQ[_%DQ;IPC.(:"5/'C4]A
M!`AG6WM!C-O8QJ0_$1LDN/)M_,,+NSQMX+L!U!!,D)OZ+?:]3ZE%8E^[G8KM
MFRVYNS^_^6NL[/5WYTU;3ZR1447F8,X2#R:MTC'(]#$2^2T]!=M[9!`&[>83
M('IT#F5^(O<\/C7#MKX!M/V<$FDE?5CXRA8PQ].J0JUSVF,FL9Y"[;E\@Y3N
M'-]U[\Z:K,>PS3EBY7U:4U@CL`D%6=]Y6@G6(=]=5]C(--9H\D<95V1!ZE]7
MW+)A+)[N<153/T`H.$XVQLB_3UZ$#\'+SX;9TW?@>Z\=GL47)<6_@9,(6WNN
MC5;>?T#;7S7;=]@OXK0);\^&5C<>T!D^BNKO:2M$S[J58'U72,]6DZE7LG55
M,@`HHZ*P196E!%'IU[UGT.*J1`+ZF,H`!]//S6\]N)96_>7^[;+$NK<L7[5!
MZ2^,^ME'M95=1[3:NC>68G[>XE*V,-3-$LR>W39[#VE;CY:P;XW\DP60L&SF
M&IX6KY]3%I5FK#/`*=.5H=N.X<IB*!S"*[--Z\=M%B].TA13`?RPZZV^%OF4
M6X<0;C?B:=TVJ8M&+V)@E;Q$=?3W)"Z&WU>Y^^%87RPW>/*V=ML9O_,8SD@>
MN-SJ!'N8L#ZNGKKDQN\!L%X`?(TK>:O7'UIP;;7,\UI_Q:JK&MYCP;.2*$F\
MH#B<307;1.1,>+IM@#O(8Z+MF@Z]H[-T8I_V,PI]@\^_+P8&5(L6^0A3);J^
M/DJ"HE"W!:&47]A5F6X=;C<P*9L&DFSCZ#Z_=75%A+S;>-O-%496`^QM5Q1,
MJ,R+RU(S,92@66#<=/SS-563(-?F!3.`@56->O$E`Z"`]1Z<Y?WKR7\QMFRF
M@_9TN5"#99,?[5&'K[O>7W.JD5C7Q)T-M)(]G6H<;>?>.]1\)/H&#UVCG>TT
MN,['#<Y6"=/J91(*K)N0^=EB+7.PXC9+6JU*)6235J>.!0P'6=%`.PTOXE\.
M_+=Z1Y^0,-KAT'PU8"25GMW=4:MW$O\`6+$/;HJ'M%6/`E<7D[H^FMX&,;U4
M]F\#U>]EJ=LA:5FB@$D%*?D:NNZK;$*Y;(Q5NYBK)7W9A<1Z[E@Y,`@!C$42
M.51,YB'*8=*;EA97&]\EP?%B?-P\BWB0N'37&UPR..AL1\A%B`>E6C*8W*WZ
M@]HKANAI387[OAY"9X7M5E[G@"\FD(=BD*@LH7-6$SRAI"`=PDRH12-CLK8X
M%4I5$51[TG`+)G#X-Z58>V9HM@\_N`1Z)4AY!!I8^EL?(TV<,O:8)O6/1I([
MZ%:S%H\Z#M^T'T'\1KJDQ?YL/&;E"K-;*EM#3J`Y49E=2%3RHC)42V0R@@(J
M,GD?*M/@G[E(0Z":.<O4#_O%#!SE_<_)GS)VS*.,=LFG4&P>`K*C>T%3<#\\
M*?6!6-;#R%-M)/N[*E/K!N_J[N86_J:V97B<FI8RF(V$MJD?'3L2+->88"_C
M'K1"PQ<2[D89^5)=)%ZBF=LHNV6(4XB0>1;DO"^3</,"\CQ'QCDH6CN5:X4V
M8'0S`,.A*D@@,"1UJG)#)%;Q!:]1&\Y%-LMX\7NS\;58EW-R,3$TBWO&#!([
MAV%?IN2*C9;,_202*914D3`1CAVJ`!U!%`X_@Y+?)/,QL'S,VR7*8)&[R1@G
MH-<D,B(+^C4S!1[2*J89"Y*D_P!W2N??PL>8+5;1W6:XX,V!:Y'C9=?+,]D*
MNSU.J9KA$3,1:(*M,56:Y&3Q!W%R,6\@3B/>0R2R2Q#%/W`8H;\\Y?*/E/-N
M2P[YL!QVA&(D3I))X;*R,YN+BS!@P[.H(-QV&K[+Q99I`Z6M:U;@E/O(?C22
M345/-9Q[4R&4-TPW,"/:0HF'H'S#U'H'-1CX=?,@FPCPKG_\A?Q5:_L_(_@_
M/6P[;Q-UL5X\,_+8M82$TOF'56Z3="BU&:J$O+IV[&[J;KT?\O#W%DY:00=I
M)%0]3`N<"?3S7W%"O'N?X*[HRHN'ND:RM>ZKX<P5S?\`>@@F_J%ZH1=R==7H
M8?AKCU\&GD^UZ\?C386L;"1]];1F5WM!L%>L%.K8V?X*1I[*Q1,E!34.FZ:2
M315=.9(JDL4IR`9)1-0"#VB/77G;Y9\@YZVWY7'V@,N*LJ.DCZ+B0HP96L0;
M:2".AZ@B_6LIF8[SZ2ENEZW_`/\`M('C4_Z:SA_0Y,?]H<T+_P`.WF1_U>%_
M[A?Q59?L_(_@_/6U[$>TV)<V:T0^V5,D)1OAZ;I%CR$UE+-&*0$FVK-5/,DF
M'DI&N#JJ1XMOD+@P@8P_FR@;\/-6;MQC==EY&_%LQ5.[QS)$51M0+OITA2.V
M^H5;-$R2>$WU[VK4]AS[QOXZ<BP#5]?YW).#I\S4%GL%<L?S]E9%5$1$"1EA
MQZTM#.014)T,0ZJ;100'H9,H^G-J;O\`#QYA[?.4P(\;.@O8-'*B'_G+*4(/
MN+#VFKE\#(4]T!A[#^.N=OS%[G8]\I>T&!:7J#1+7<GE:A)7&-9FW-:<15HR
MG:+Q8(]VTC(B!6(,TA5JX+$5$EGQ4#%,\=+'311**A^@O*'A^X>6'&<_-Y=/
M%#'*ZS.H<,D*1(069AW2[WL0M_JJ`2387V+$V/&S2FU^ON_Y:[J]<L<26'=?
M,&8EF7B<A,8QQ#C>@2SY%0RJ+R3J%/AX!^X;J'`#';JNV!S)B(=>P0YQ!R'<
M8]WW[-W6$:8<G+FE4>I9)&<`^VQZ^VL/(VN1F'82369N8>O%.*4XI3BE.*4X
MI3BE.*4XI47-D=*-4MO6<:TV0P91<JJPK=1I"3,XP796F%9K*BNJRA[?!NHJ
MT1C%5P85#((O"(F.(F$HB(CR3\<YIRKB+L_',Z?%#F[*I!1B.EVC8,C&W2Y4
MFU1W?N)<<Y.JKON'#D,HLK$$.H[;!U*N!?K8-:]0CK?@;\5U9FB3B6L+2:51
M7(X0CK1D;*EB@DCD,!RE/"RET7CWJ'<'JDY(LF8/02B'IR;Y/GMYI94'@-NA
M12+$I#`C?I+&"#[00:A^+Y,>7&)/X\>WZG!O9YIF7]$R6/N-Q6UVI5"J4&M0
MU-H]:@J?4JZQ2C8"L5B)8P<#"QZ/44F47$QJ#9BQ;$$PCV)D*7J(C](CS5.7
MEY6?DOF9TDDV7(UV=V+.Q/I9F))/O-;+Q<7&PL=,3#C2+%C%E1%"JH]046`'
MNJXN6]5Z@+M#XQ]+]RLD5_+6P^*7=XOE7KD;4X290O=^K)&<%$S,E8&#,8ZK
MV6'C7`HRLNX5]Q1(ZAN_M$PE``">\8\S.9\.VV3:>/98@P)9&D93%$]W950F
M[HQ'=4"P-NE[7J%<B\O.)\KSTW/?,8S9L<816$DJ64%F`LCJ#U9NI%^M3X(0
MJ9"$+Z%(4I"@(]?JE``#U'U'T#D"[>M30"PL.ROMQ7VM6V4O"UXS,PW:;R%<
MM6ZPE:;*^<2<\ZJ5GOU$CI.3=J"L[D5:_3+5!U]%Z[6,*BRB+5,RJAC'/W&,
M(CM#:O.?S+V;"3;\+=)?NL:A5$B12D*.@&N2-GL!T`+&PZ"PK7.Y^4WE_NV6
MV;E[<@R')+%'EC!)ZDZ8W5;D]38"YZGK6//[@OQ3_P!6,W]+.9__`%!YDOZ^
M_-7^<_\`P,;^2K'_`-2?EM_F#?Q^1_*UL_QAA['V&\45/"6.812O8VH]5;4J
MK0))25?JQ5<9M3,VS$DO)/7DPN=%N80!95<ZW7U$_7UYJ_<]WW#>-UEWK<7\
M3<IY3([Z5&IR;DZ5`4=?0`![*V-M^UX6U[;'M."FC`BCT(MV-E`M;426/O)O
M4:M4_'%IUI/9K9<=:\2ACZR7>$9URS2BEQO-I6D89C(&E6[,"V^R3J30OQX^
MX<R)4SJ"4O<(@``$EY5YB\PYKC18G),O[QC0.71?#B0!B-)/V:+?ITZWM4?X
MUP/BW$9Y,C8,8P32II8F21[K<&W?=K=0.RW8*SGL1KEAO:W%<YA7/5-0O>-[
M"[AI"3@%I&7ASG?0$HUF(EXUEH!_%S$>Y:/VA#`=!=,3$$Q#=2',4<'Q[D6\
M\5W5-ZV&8P;E&&"N`K='4JP*N&4@@^D'K8]H%9G?=AVKDFVOM.\Q>-@2%25N
MR]5(8$,I5@;CT$7%P>A-6_J_J3K]IICU]BW7''[?'E)D[-(W"1BTYB?GW#^Q
M2C2/8.Y%W+V:4F)=<XL8INB0AEQ3232`"%*'7K<<GY9O_,MQ&Z\CR#D9RQ",
M-I1`$4D@!455'5B>RY)ZU0X[QC9.*8)V[88!!B-(7(U,Q+$!22SEF/10.WI:
MK+VST(U3WB;TAMLYB\F1D\=*SZM/,%HN%76B36A*+2G"^_49Z"5>)/20K;ZB
MXJE(*0"0"B)A&\XGSSE7"&G;C.5]W^\A/$[D;AM&K3TD1K6U-V6[>M6G)>%\
M<Y=X/[?Q_'..6\.SR(5UZ=75&6]]*]M^RI.TRH0-`IU5H56:*,:O2ZW"5*N,
M%WCR1590-=C&T/$,U7\BNZ?OC-H]FF055U5%E.WN.8QA$1C&;E3[AERYV6=6
M3/(TCFP%V=BS&P``N2>@``[`+5(<3%@P<2+"QAIQH8U1!<FRH`JBYN38`"Y)
M)]-:8]C,*Y#T_P`O$V*P<BJ%$=R2SQ^S;H*N8^KK2BP&F*Q8F2(@8]+FU1ZM
MUNI0:G$J?<FHF@<W!/F7PCDGDUS)?,C@BD<?>4LZ@$I`9#]I!,H[<:4_4;H$
M)"W5EC8Z4Y'LFX\.WD<CV(?_`*\L20!<)J^LC@?XMOR3^2>G0A293Q^7].]^
M\7N,19YJE+E"3::/SS%F3P;`D,FB':E)TV?5.R44>(&.86KR/7;2:`"/HF/4
M1Z=\I?B,V+>)H<[9\\[-RU!8PO($)/I$;FT<\;?O>T_E1BMB<<YUM&\(H$@Q
M]QMUC<@=?X#&P<>KT^M16MG(7W9'2&TS!Y6@Y0S]C&,=*'7&O,+%5;C$-R*J
M>X5&,=VNKOYQ)LF0>TGOO'1NGJ)AYVSMOQ+<TQX`F;C;?E,!T<HZ$^T^'($/
MR*!4^7<9;7(4^VI%:_>%_P`:^CTA'Y8M;%?(5LK)D9&+NVQ%JB)>+@Y)GW*)
MR4!3V["`IY)1,X`*!U&+QTDH4!1.4_0>0'G_`,1?(\K:Y?V[N&)M&R%3K$9$
M.I?2K2.YD:_9I5AJ[+'LJQW#>HL6$S9LL<,`'4DA?I)N?<.IJ\LV^38S*U14
M=@V%;3-9@Y1-W9;#8FCAN2VQR)_97BH1H8I7<-&+BJ`A(+%!<5.SM2*3K[GY
MT\Y^*(P[O%B\#@2;;,>4-/+,K+]X0=#'$OUHT-_US#5JTV0+];36^>9Y3+2+
M84#XT;W=W!'B`="JCM5?X9ZWMTMVR02R!IKO]C1?&65:Y2+C'S":2DQB?*+5
M@6682)"=H/8!==1%8[QJ8YOAY*(<$<IE'J!DC")0Z/\`*SS\V'>Y8MRXMN3;
M;R11WH'<13`^E0"=$Z7_`'NI6%M2CL$_V#F6T;T@;%E$69;K&Y"N#[+]''M6
M_M`/2M=%R^[5^/"RS"\K7I78#'S)RX47^SU:R5&2<*U34-W%;,#W*I6>:103
M`>A?<>*B`=/7G7.)\1WF#CPB*=<#(<#Z[PD,?:?#D1?F45,QN$X'72?DJ7VK
M?CUT,\71[-D>AOYFLV6PP`UVP7W*.3)*8F96OE>MI((5M!(JQ5=<_P#Q!F15
M,K6),[`X"!#`!CE-JKS1\],S=MN67GFX8.'M$#^(J:4B&JQ%UOJF=K$C2K-?
M]Z2*Q>Y[UBX<)FW*:.*$=>\0/F':3[!<^RID8OV;P1G%!XPJ-TB'KLQG3)U6
M+"0L-,NFPF4;F4)"3`(JR,>]1^L!DRJE%,X`<"FZE#2W$/-;@W,R?V#N$?WQ
M6(\*3[&;H;!E1]+,IM<,M^A%['I6$VCE.Q[U<8$Z^*#]1NX_O"M8D'T$7]MJ
MA3<?"'XOKO9):U2NK%>C9.;>+R$@WJEPR-3H,SQTJ=9PLSK=9M\7`1155#B/
MM-&R"(?@('.E,/SI\S,'&3%BW21HD4`:XXI&L.R[O&SM[V)/MJ5#,R`+:C;Y
M*LQWX(O%$B447>MZ2?O%%/VCY;S$510#@)1*0@7_`-PPB`_@#KRK)Y^>94)'
MB;JJMZ!X./?Y!X5>6W"5/K.!\U;;:A5H*CU.KTJKLQCJS3Z["5:NQXKN'0L(
M*OQK:)B&8N7BJ[MP+6/:)D]Q4YU#]O4QA,(CS5^5E39V3)FY+:\B:1G8V`NS
MDLQL``+DDV``JB3J.H]IK7;E_P`.GC?SE>IS)5_UCK"ESLSQ:2L<K5[%>**A
M-R;D0.YE)"'I=G@H163=J=3K.`;%674,8ZACF$1YL+:/-WS%V3"3;L#<Y?N<
M2Z45TCET@=@#2(S6'H%[`=``*KKE3H-*L;"L8_W#'BO_`*LX_P!*V8__`,^Y
MD_Z]/-#^<O\`P,?^2KU]]R?WWX*V08DP%B3!V&:[KYCBG,HK#]5@9&KQ%)DW
M#ZSQP5^7=2#N3B9!6S.I=Y,,GZLJX!4CM18#IJB0>I/J\UUNN^[KO>\2;_N,
MS/N\L@=I``AUJ`%8:`H4C2+:0+$7[:H/([OXC'OFH`WWP?\`B_R%+N9V0U;K
MU<D'KD[IV%`M5]H46JJH;O."=?JUHC*^S2,/[QNU2+Z^@<GF!YU>9FWQ""/=
M))(P+#Q4BE;]*1&<_*QJLN9D*+:KCV]:DKK3X]],]0'SF9UYP#2J#97K8S)W
M<>R3LMV69J$[%VA+?;9&=L31DY+^E00<I(*?OB#R.<DY_P`PY<@AY!GS3XRF
MXC[J1W]?AQA4)'H)!(]=4Y)Y9?UC$BIE\A]4J<4IQ2G%*<4IQ2G%*<4IQ2G%
M*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*_!TU;/FSAF];H/&;M%1
MNZ:ND4W#9RW6(*:R#A!4ITED54S"4Q3`)3`/00Z<IRQ13Q-#.JO"ZE65@"K`
MBQ!!Z$$="#T(KRRJZE'`*$6(/4$>HBM?&5_&U@^^NW4M3W,OBZ5=',LHV@2-
MY.K&6,(F,<M=D!#X(#*#U[&CEND7]Z0.<Z\M^&7@F_S-E[*TVU93&Y6("2"_
MK\%_J]?1&Z*/0M:\W;RTV+/<S89?%E/H6S1W_,/9[E('J%8$3\<.=(8/A*QL
MRNQC2?5203&[1!2D`?J@#2.LBK8G0/P`/0.:_3X:N>X/V.U<H*8H[`/O4?\`
M>I.5'R5@!Y;;]!W,7="L7J^U7Z`Y%5J#\7KJ6D49'+&<YZS`0Q141B(U<7RI
M.O4Z9)NS2DVHW`P>G4K81Y>8/PK39F2N3R[?I\JQZB-#J/K'BSR2D>_15:#R
ML::02;OG22_FJ;_I.S6_1J>V-=9<(XIK4C5ZM0X=5E.,Q86-Y/-T[!*V1J8`
M[V\T_DR+G<M#B'7X<H$;%-ZE3`>=!\9\K^#<3VR7:MJV^$P9":)FE`FDF7U2
ML]]2^G0+(#U"BI_MG&-CVG&;%Q,="D@LY<:V<>IBU[CV=%]E1/R;XR,.VMVO
M)X_G9[&;U90ZP1K<B=CK22H^I?A(^160DV!`./7HF]["AZ%(`!TYJ+E/PN<,
MW>5LKCN1D;7,3?PP!-`#_!1R)$'L66P]"BHGNGEALV6YEV^23%<F^GZZ?("0
MP^1K>H5B!/QT9^C0^#A=G7+:,)T*FBFO>H\"IAZ`4&C2R*-R`!?P`;IR&CX;
M?,+&'@X/*"F*.P7REZ?FK,0/GK##RXY!%W(-T(B]\H^@/:KDK'BZCWDDG*99
MS+9+<<#`*S:%8"P<."^HF3/.SS^P/2D$?I[$B&Z?0(#S)[7\*F//E#+Y=O63
MF$'JL2:6/L,LKS-\R@^VKG%\K(WD$N[9LLQ]2BQ_3<N?H%75D'Q>8FG#E=X\
MMMGH#M,A.UF\[+;$"LF0I2K$!\LSF6RB@E$QQ!X<.X?JE*'IS+\B^%?B.>?%
MXYF96W2@?5:V1'<#M&LK(I/:?M"+]@'95WN/E;M$YU[=-+CN/0?M%^DAA^E[
MA7Q1M(,RTSVFOZ_5I"/1,`$1!:WM0]L/0"@U&=<($Z%_``].>-A\B>;;):+^
MD+28P]%\A>GYOBL!\]?,#@N]87<&X%HAV=9!]&HBIDT+#BE5]M>7L:\T\*`=
MQR('2[Q``Z]Z[IP[<'`1#\8<W5Q[A3[3:3-RFGF'LM]+%B:F>W[*<2S32F1_
M=^Z236<0````#Z```#_`')Z!86K/=G2OGBE.*4XI3BE.*4XI3BE.*4XI3BE.
M*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI
M3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.
M*4XI49\[;&#B:S8]QA2L<V/,N;,KHV>1I..*Y)PM=;(5FDIQ9[A>KQ<;$X1A
MZ;2H!:=8-3.3$=.W3]^W;-6JZAS`21[)Q_\`:F//N6;D1X>S8I19)G#.=<FK
MPXXXT!:21@K-:ZJJJS,R@=:B1Z@6)L@]/[GOKP5/9)_$P5AE=HL>MM3P@IZN
MP#.;OV3\?3>.;@ZM"3T\9]D+]'2;!-=RFX8*(.&LDQBW::@D$J:A#@?GO+X]
M'+/'%QG(.ZZT=BL4,JRQA+7\2(J;"Q!#(SK:]R"+4,8N!&=7N!O\U>V3W/U-
MAF5$DI/8C$C.-R:S/)4615NL-\OL42G,FKIYMJ](Y,V0@0L!#,?CUS),Q=E%
M$%/<`2\\1</Y3,\\<6WY9DQC:4>&UT;3KTD6N6T=[2+MIZVM012F]E/2LJRV
M7<6P3?(;R:R#4(MKB5LQ>Y/</YZ.;(T!I)0R-ACW-M457*6"0>P3A-XD9P)`
M.V.50.I1`>8N+:MRG;'2''F9LHD0@(Q\4AM!$?3O$,"IM?KT[:\A6-@!V]GM
MK'UBVTUDJ5_0Q79<[XOA<C+6&)J9J8_M\0C/L[)/LXM_`0TJP%R*L.^GVLVS
M,P([]GXPSE(J/><Y2C?X_%N1Y>`=SQL')?;Q&S^((VT%%+!F4V[P4JVK3?3I
M)-@*]"*0C4`;6K'>?-XL&X,L$7CU2Y5"T9ADK_ANC_JG:6MDRM;0N7LAU2E-
M9%X@1M(_".8J)LQIDK%8J3AXR:F,GVD."H9#8N%[WO>.^X"&6+:%Q\B3QRA*
M'P(GD(!N+AF3P]0N%9NO46KZD+N-5B%L3?W"OC$V\F"LD7BPXIE[O2J3EJ+S
M-F#$$-C:3N48ZL]C<XIN5@K"4DU:"DR,V?VJ-KZDHUC#`9W\((F)[Q"&4Y]W
M7A6^;=A1[I%!--M38<$[3+&P1!/&CV)ZW"%PC/\`5U=#8FU&A=5U6)6P-_?6
M16^VVKSMU;&+78+#SEY0X*?LUV:M\@UE9>HP-6L)JG8I.R))R)CPK:'LQ?@%
M_B`3,1T()].XQ0'''BW)52)VP,P)/(B1DQ.!(SIXB*G=[Q9.\+7NO6OGA2=#
MI/7LZ5^2>W.M"V.GV64LTT13'L78T*=)V,DL!DHZVNBHJ-:N_CP3&69V)T@Y
M2529*-RN5452*%(*9RF'T>*<C&XKM1PY_P!H-&9%33VQB]W!^J4!!!8'2"""
M;@BGA2:M%CJJADVQQW/W'6^#QJ_A<F538J=RE!1M\K%C:.(JNN\6TB9MLJBZ
M;)-G*CQ^=Y"J1Z[4ZC5=DOW>Z7N().5SQ;<(,3<9]Q5\;*V](6:)T(9Q-(L:
MV-Q868.&L0P[.V]/"8!BW0K;Z:KX;-XL<3,,>*N%%EL>2&/,L9&?9.:9#J`P
M,9#8=G(""N+I)@,B,E,P4.XF%1?R[0JD;&F;>VX5(==$#6W]'-S6%Q+#.N>N
M1!"(3%)J+9"NT8OILK,%&F-K.^JZ@A6M\\-K=0=5P+6]=>NB;4:VY.-=@H&<
ML7VPF.(@EAO#F'N,*X95JMJ)NU2V>1?_`!961:OV,%^LD50S$#(*%%4#$,`?
M,[C'(MM\'[_A9,1R'T1AHV!=^G<`M?7U'<MJZCIU%?3%(MM2D7[*]V)-E,"9
MX=2S##N6J1D20@6+&4F8VM33=[)1D5*KNVT3+/(_J1ZC%2RS!8&CH2>PZ!(P
MI'.`=>>-UX[ONQJC[OB3XZ2,0I=2`64`LH/864$:EO=;BX%?&C=/K@BL99PW
MYTWUMN2&/<X;#8\QY=58UK,KUN7D73F3AX9\<Q&4S94HEG(EJD0[$@BDZDQ:
M(*%#N*82^O,ELO!>7\CPSG[)M^1D888J'4`!F':J:B-;#TJFHCU5Z2":0:D4
MD5Y\S^0/2S7BSPM+S/LCC"A6N?B8^?CX&4FS.9%*`E>T8R?ET(IO(#7X%^4X
M&2>O_AFJA![@.)?7GK9N!<RY!BOF[-MV3/BQL5+*MAJ7M12Q&MAZ534P]5$@
MFD%T4D50Z1N37GF1=P(C)]CP11<9:LNJ2J^N[#,[29F(Z"M=><SQY/+]>?P$
M$QQ<NHFFD,<C\?(_,$E.XIBFZ$-6S>(SKM^T2[9'G3[GN@DM&<<JK,CA;8[A
MF,X[=9TII(M8]M?6B(52NHLU_1^#UU6:=Y!M+;]0\F9-JNQ>.Y"DX:8L93*<
MPX?/8=2B1$H<$XJ9L41-,(Z;8PLL8?X(\%L+9UZBD<X`/*69P+F.!G8VVY6W
MY"YN8Q6!0`WBLOUE1E)4LOY2WNOI`KX8)@P4J;GL]M57#N]NG>P5VL>.<*[&
M8LR5=*G7RVN>@JO9&[Y9G6^C7WYI%UVIL)&/8&?(E=J-E5@9G4*5?VS#TY1W
M?A'+M@PH]QWG;\K&PI9-"LZ$`OU[MNT$V.D,!J`)6]'@E1=3J0IJDXR\A6DV
M9;].8QQ?LQBJZ76N15BG)6+A[`4[0D+42@>U2S&?710KLQ&UQ(P'?+LW:Z;5
M/ZZ@E+Z\K;EP'F>SX$>Y[GMN5#A2.BJ63KJD^HI07=2_Y(906/07-&@F1=3*
M0*K6$MYM1MCKE*8]PAGR@9&ND3%KSRM>@Y%P5](5]L[*P<V&N_,&C)&UUYN]
M.5([^+.\:$.8`%0.H=:.]<)Y9QW#3<-ZP)\?#=@H=@+!B+A'L28W(ZA7TM[*
M/#+&-3J0*E=R+52K6WBOR$OL@R>'WLWK?D"G8RSSE.X8>QGDDMUQQ:?C+=4W
MU]9"K8:-"SOVT@8"1''$D/QP-7*3/\T+H$2*=X;$W3@*;?%EI#N./-N>#BQY
M$T/AS):.01'N2LGANP\9.[J4MUTW(M5PT``-F!91<BQ]-O3\M2B1VQUB<2-J
MB&^P&(%Y2BPEHLEU8)9`K*CJH05*G35BVREG1+(B>":5ZPD%FZ,Z!+VG'0@^
MHAUC)XOR18XI6P,L13NB1DQ/:1I%UQJAT]XNG>73>XZU3\*2P.DV/97G;;;Z
MTO,=3&66N:**OCVO3S2K3MC3E0%&'LT@+3Y=7I)A[?S5G-R))!`[9JH@5=PD
MNF=,IB'*8?3<4Y&FXIM+8<XW"1"ZIIZL@O=P?JE18W:]@002"#3PI-6BQU50
MR;98WL%DUTCL924)E"K;"7;(=(976KV)HO'5B1QUCFX7R53?-4VSA9Q(D<5$
M\<NR4,U<,UE>Y0.I!(-8\6W#'Q]PDW)7QLK`ABD,;H07$LL<2V-Q86DUAAJ#
M`=.V]/"8!BW0@`_.:MF\;]:N4&[X@ILUE2J*-LT'R6A5[DQL,$XIK=YBU]'P
M\\S?S(2(%47=6!\:.;"U*X(=ZW53.8@E];G"X+R?/PLO,@Q9;X8A+QE'$A$P
M+*0NGL"#6;D=T@B]?1#(5+6/=M]-?.)=Y,%9*NDWBV6NU+I.6F&8<O8DA\:R
M5QC7EGL#G%5QL5:3D6[0$61FKZU1E=4E&L:<!=BT$3)^\0AE.-TX5OFW84>Z
M1P33;4V'CSM,L9"()XT>Q/6X0N$9_JZNAL3:OK0NHU`$K8&_OK(R.VFL#A:W
MMF^P6'W"^/Z_-6N](H9!K*RE.KM=GQJLY+68J<B881K&60/@51<^V8KHQ4^G
M<8H#CCQ;DJK"S8&8%R)%2*\3CQ'=-:JG=[Q9.\+7[O7L%>/"DZ=T]:K%.V2P
M'?ZY$VVG9=H<]7IRZL\;1DBSL#$H.,A2!0484@S9PHB\;6Q\B8JB,>JF1TJD
M<IRD$ABF&EE\>WW`R&Q,S$G3(2$S$%#TB';)<7!C!Z%P2H(()N#0QNIL0;VO
M\E>^WY_PE0(:YV"YY3H]<B,>6"+J5U>2=@CT`KEKG(V)F(2K2*'O&<IV69BY
MUDX:,"D,[<I.DC)IF`Y>M/$V+><^:''P\6>2;(C9XP$/?1696=3:Q161@S7T
M@J;D6-?`CL0`#<U'RY>0#7:L+X7F8[(="L>+LJWG(=`F,IL[M&(5RA6''^.)
MF_.(B43%%=1[89!>-1C@C.]!ZFX=D^H8WYL<_A\#Y#DKF0OCSQ[GBP12K`8V
MURI+,L09>RR`,7U]5(4]0.M5%@D.H6.H`=/7<VJ5^/LB47*]/A,@8UMD%>*3
M8VZKF#L]:D6\I$2*;=TNQ=`@[;'.3WV3]JJ@ND;HJ@ND=-0I3D,4(OG[?G;5
MEO@;E%)!FQFS(X*L+@$7!]8((/8001<&J3*5.EA8BHB'\G?CZ2N3+'Z^W>#V
MUO?6*P5,L,[N3)HHRL57<*,YR,FG3D$F%>59NT3I`9^JV365(8B1CF`0"5CR
MUY\<-L\;3FG$6-)-0C)NCBZLH'5P1U[H)`ZFU5?N\]M6AK>ZK]QYO7IYE;&V
M2,PX_P!C<5V+%^(':K+)UX1L[1C7Z2NFG[B9IY[*?`E:-7Y!_@:_04'P^C<Z
MH^G+'<.$<NVK<<;:,_;LJ/<\L7ACT$O(/X(6]R/RAVK^4!7QH958*RD,>ROW
MQ9O!J5FJK9"NF-<^8]GZUB9@$MDV1<2JE=-0X8S)Q(HSEJ8VAO"R,+!.F#55
M9!\NB1HX33,9-0P`//FZ<+Y7LV3CX>Y8&1'DY;:80%U^*UP"J%"P9@2`5!U`
MFQ`HT,J$!E-SV>VH0P_E\P_E79\F"M<'F.\Q47_5:ROGM[F`EWE*[!PMMQL]
M>-TJ-.,WU3.+&#D6:2+Q69!10B+5;W$T5BAU&:3>4N[[7QD[YR)<C#SOVI!B
MC'\,.S1S`'Q5(?JP-U$=A<BQ(-5ONK+'KDN&U`6]]2`JWD5P#6]8L);"[-9:
MP;B(<SQKMQ`M*ADM7)M4L+YI(O6JZ&-YQC78J?O[)JU02.X<-H@@-U%.PX!T
M*8V!R?+[?LGDN;Q_C>)G9?W-@&,D/@N@(!!F4NR1$F]@TG4"X]E,P.9#'&&-
MO9;Y_57J8[WT.V9RPA4\<7#!%PP?F+!V0,TM,CIY>%K?G,50WDLSD'U/QB6L
M.`L]1CEHHZ<G(FDVBD<L15,R!C)B'*<G",[$V3-RMQASX=ZP\V+',7W>\0:4
M`@23:QHD(-T30P<$$,`13P2$)8,'#6M;I\_KJY<:>1_1/,F0ZIB?%NTV(+UD
M2\QSB3J56KUG1?/IQ!JDZ<+MV:A4RL_FQ6S)54&)U2O3(D%0J0D^MRAN7EYS
M?9]OEW7=-KRX-N@8*[NA`4D@`GTZ;D#5;3<VO>OC03(I=E(457T=]=.'.:$]
M>6^Q.-5LPK616EH4Y.9,<R]V03]Q:D(SI6XUE:ZHAZ&ARO1DBG^J*/=Z<MVX
M-R]=F/(&V_)&T"/Q#)I[(S_C"M]8C_[33HMUU6KYX,NC7I.BOVSEG_(N*+6Y
MAJWB>.R!&%HT39H\[>VRD/.R<[*Y/IN-DZTDQ"F2L2W[E+DF\(X.^ZBFW4`R
M1"_G`\[+L6W[IBB;)RFQY/'9#>,,H589)B]_$5C^K*VT]I%B>RB1JPN38W_<
MOZZMW_6PMGZJ_P!8WZ@[I\Y_79^K#]6GQ@_;G[/?$?&_:'Y?\J]G[4_9?\_\
MD[^SYE_`?C>OY[EQ_1;%_:G[/^_P^#]S\;QK?9:[6T7U7T:^GB6^IW]'HIX8
MU:=0[+W]']WM^6O/L'C3,\/G?$^T>"JO`Y-F:9CS(>&<C8CF[2WHTE;,>Y`G
M*5:V<[1+A(LGT'&7&GVFCH'%I(@W9R;!VNF+ENJFB8?6P[CL\VQY7&=[EDQH
M9LB+(BG5/$$<L2R1E98P0QCD24C4EV1E!TL"17V-D*&-S8$@@^T>OYZAI7-1
M=CK<\?/;G5Y^(QPZVUU0RM6,.9HV'EMAIRGT?$3B:>93F7,[9']KAFB]FE'[
M9RTAF,@\2`S4![TS`4H3#(Y9QW#54PY(WW$;3G0/D8^(N(LDDX40J%0(QT*&
M#2,BGO=A%53+&/J_6TL"0+7OV?\`+67MA<%9\2R'MDZQ=B.HY@KFXNO]-PXE
M+3UZ@J<WPY,UB%R-477VPB9E@[?63&CYED3YP5.%!S(`^0=HF:?PE-P3$[!O
M>Q';]J7<\N7$R=HSY,C2D32'(5VAD'ALI`28&+P[R6724.ONE3YC=-*ZC8HU
M^SM[/Q5@S)^IVUE7I.U>#L:X]K^88/93!.$Z+%Y=G<GQ%()6;!C'"41AJS?;
M&O2;"6L,G(37V91E(]1B5=LN=Z9%TLU]H53YO;.5<7R<S:][W*>3$GVW.R)3
M`L+2:UFR6R$\-@510NLHP:Q&G4JM>P]K+'J5V-M))M;UF]9JRQJ/EBWXW\@U
M?AH2KJV#8S.F'K[C91S,LV_S&NT*BZX0SM:<?"U,>)=QLWC:7,U14%00[4U"
M"45O3"[3RO:L3<-@GG:40;?@Y$4UE)L\LN6P"B_>!6:/41;T@WM5-9$#(3V*
MI!^<_CJQ;+KKM`R>9;P]7L0U:STG).]V/ML"9Z=Y0@H8Q:.WS5BS*$W5Y6DN
M8MY;'UVI,935H5@3N)&N(MJU,1VF<OPO+_&Y#QF1,7=\C+EBS<?8Y<'[J(6;
M[0X\\"NL@8((Y&D$C?EAV:Z$'77M9(^CDV(0K:WL(^FO:TUSV+F))7#DAB"O
M5NBG\A]@W"<9\_6#5WI`I$7L`[S97(V$IS!L-S3R/9V35M`+_$)ILF<<X74,
M\/VE:C3?D/'HHQN\>7))F_T?7`&+X3C[1L48SEI"?#\%"6E%CJ9PHT#JU?#(
M@&H'KX>FWR6^:JE+Z2Y0?Z3.L21C*N0668K:>V['A$0UG/5&60VK+;>S9Q@*
MS+9#K\2ZDH"9M-*58HHRAFSH\5))MA4*HFV$.4HN9[8G,QNLID?:FVR/$U,G
MB&(G`3&9UB9@K*D@8E+J'0M:Q:@F7Q=1ZKIM]%NRK7=X"V<CJA9;;C;%F6Z%
M;+UFK%\IG"OOMP8RR9RS+B.ET.R5[Y?5<LO$G%;Q5(PU@DHOT:22#^6A8]9'
MXUBHHD`72[[QN3+CQ=QRL2?%@PYEQG&`4QL>>25&O)`+/.&0/]9"J2.K:'`-
M?=<9-F((`-N[T!]WIK$3;QP;!9"JT!5)^;G<#M)?93;/*5AG*]EL^6+U`4O,
M^&4*I4XV=N%I8C+Y`/8+.3X>S(>\W=.(]1=!-Z5-0%^99_,38=ORI,N"-,YD
MVW!@17@$$328^1KD*QQG3%I3K";$*X5BA(TUZ\=%:_UNZ!V6'0_1[*D'?M:=
MC<HTV-0E<9XKQ]9(C07<K5A:KT"QM&N."WK(I,80F+75#9"P;.8#'5FCJ4NY
M(V<I$7@$C$:K`J)`5/@,'DG'MKRV,61E9&,V^[?FAY4)F\.+QFF$IN0TR&0*
M6!M*;N+7L/`DC4GJ2-:GKV]+W^7\->;;74RXW2LS\F$GC^@4ZO>/Z=Q'-62S
M/_A*I&VBM9,Q'DMI7[4TBV2KL,7OX3'TBSE'**:A&[!RJ!43]XD-ZXIRO$PL
MF./1D3Y<F_+.J(+N4>&>$LA8V\8-*C("1=@+L+7I%(%/I)UW^@CY^M5K3/+%
MFV)VZSAF!S6L<Q%8A=<L%XO2?8GRLTS732V-G?LR6YY!CD2'JU8J[^=91,^V
M<K,8[XSX!HZ:BY4277]A.CR_:\;C_$\+:%DR6RGW#)FM/`<:308L=`WA,[N%
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MXD[4S`&5V+S0XULIXL[K/-^S,;.AR1H&I/O3]R2/40LA"]6%Q<%EO<UZ3)C3
MP_3I#`_+6/Y3QM[0Y*Q)NX=[KM-T#.F>-4H[!T3=<P;V/-D)6^349=ZK.Q4&
M15:FP\?3J;`Q\*N9J[>+.'Q/<*@5,A!.(W\7F+QG;=UV4)N"3['@[H<EH\?;
M!B+$IC=6;]8QDD8L-2J`IM<DFU>OO$89.\"BM?HMO_J:D1;/&7F*T[`8*L,1
M%T?'U#B_%1D?37)5N@)"/1FH++UXJ3FMLY-C`QK1DXLD9%*O3+`\!5/J!>@=
M!'J$>Q?,G:,;8<Z"9IY\YN4P[A#&RDJT$;ARI8DA"U@--C5,9"A"#<MX@8>Z
MJ%A[3G=J6TN/XYLFZ]X"Q!4ZSKIE7#<5ME3LHL[4_FYR<B%XFM35=QRRJ$9:
MJZA=CKB:UJNW@*.6YE@*0QE`(6ON_+^&1<Q'F'MN?GY>5)N,&0V#)`4"JK!G
M5YC(R.8[?8!5L#IN0!<_7EA\7QU9B=0-B/W?P51]%]#=E,39PUVON9]=YM&U
MZV8GNF.8?+\]O=,95I2C!Y0W]985S%&%#4ABXJ-4MDH9!55I(NB-X9(.Y%-5
M0A.E;G'...;KLFX8.S;@AQMQRHYFQUVQ8)+B4.7GR/%(D=!<!D!,G82`37V:
M:-D94;NL;VTV]/I-ZW\8YD[Q-4&G2V3*M%4C(4E7(A[=:?!V$+9#5FS.&2*L
MS!Q=G!A%A/L8U\8Z23OX9#WR%`_MEZ]`T3N$>%#G31;=*\V`LC".1DT,Z`G2
MS)=M)(L2NHV[+U8M8,0INM:+,+:#9JK1\2PB.K>+<-94H&P3_)4[NM#9ACW]
MV?T17.,UD*RP,/3JO`DG)MSE'&[T:L^CI9VE%E;/5%%_=]E,@[MWGG>S9(RI
MVW/*S-KGP!"NW-CD1B7[LL2,TCOI403#QU>-2^I0!:Y-7C3*;]XE2MM-O9;T
M^H]:E!.Z2Y+E]+;[B"+8U>O93?[4WK8EDQC[$I7F-[CVNW<OGBJUF>OM?BW,
MK!R5MI+=BQ^9"W>*1#L41,14C;L&-0<SVV+F,&[2F63:UVN+$)9`YB)P%Q7=
M8F8*RI(6;1=1(M^H+7KQXRB8/^3I`_O;=GOJSW.`]GV-.NUNQMBO*^/+S>LJ
MX8<9BCI7<",MN;\R8=H=?M\9)UZFY1>-G5:Q-)1$M/LA070DD'\K$MW*`N8Y
M4Z`ENAOO&Y,V#$W'*Q<C!@Q<@8Y7`,>-CY$K1L'DA!#SAE5K@H521E;3(H8'
M[XD9(#$$`&W=Z`GUCTUC)MX[,_Y$J;"J3TU:,!-;%M?L1EZ<L-:S(?+&2JQ0
M,HZQFQK`(R5ZM;):4NDG.7,?AI]N"R:YHU9=%!Z"8D7YDF\P=BV_*;)@CBSV
MCVK$@5'Q_`A>6'-\9B(T-HPL?6(V(UA2R7NM>O'C4W`#=T#LL+@WJ4*N,MFX
M5YI;D5'`F-5[-K8&7\5W/%V*[M`4VE/*E<JQ!U*MY(Q7\_:-&,)4BEJ;=R:M
MO/9D8UL\%`AG)FP&7C*[EQN9-YVXYV2,;<?`GCFGC:2021NSO#-I)+2=\CQE
MNCLNHZ0UEI:HSK74;-8W(Z^X_CKUIZJY/)CZ'@ODM9+.-?)@_P!IW1R2K0H#
MC)SL?-9"3F?C`:E.K91H3Y-,6H_GOI;=_:'3GD\IVS[^TY>7P3QL80[I_7##
M6+3:_P!3Q03J[/RK7K[XJZKWZ>'I^6UOPU1#Z?Y,C]-H[',-5Z&KEBI[2O=E
M#T]Y(-&-6RHG7=NY?/$34;39FD6Y(D\N5,29M@=NF[E-G(%0!<#)(&$*_P#2
MW;9.7-N,LDXVN7:QA^(`2\!?`7&:1$+#I')J.E6!9-6FQ84\5?%U7.DK;W=V
MWT&K#MVN>S=VM62MGD\2P5<O,GL-J/E&MZZNLB5E:=GZKK4PLD#87\S?XTSF
M@1F0KK'W9?X)/XA=FFR@V*#AX4R@@WOL3D/&\+%QN-'*DDPEV_/A?+$3Z5?,
M*,@6)K2F*,QC4;!BTCLJ&W>^B2,`1W[NEA?W^SMM5BY&I&9<;24AMMEFMX5Q
MG*1V]<#G6MXFR?G.$B*I9:_,ZCQ>N+2)D<L*5Q6I5;)\)+).I6/^(;K1P*MS
MMTW8^ZDY&]V[-V?<8UXIM<F;DQML;8SSPXS,Z.N>V666#7XCPLNF-[$/8ABO
M0K7I65OLEN>Y:X'\*_9ZJJ6G^-\D9EM^/=BW-7J;6H-=]=OLT.W$78U+%7W5
M1N>%9#%-3LN/IR3K]?7N\6XN*0I(R:+)HBY2(=TV[VQDSJ4^6[EMVSXD_'DD
ME.6=BP,<`IH821Y(G=)5#MX9$?4H68@V5K-<!*RH#'UOH4?,;]?56Q?5/%-J
MQ#5,JPML9QK%:U;*[$Y.@6\6]2>-_LEDK*EBN%;75]A-)-F^=1LJ55PATZI+
M',`B(]1'7W*-UQ=VRL6;%+%8MMQ(6+"QUPP)&X'4W`*V!](%6\K!R"/0H'S"
MU:)'GB=V4>ZKGQFZH.*W>25O+B?;5PX=66#73<:\K6!5ZX%><6BCJ+RJT>IV
MGAC]0,`B01$.;O7S4XXG*/VDL^6-N_HG]Q`",+982PLNKHH/^,^4"KW[S'XN
MJYT^%;Y:O'83Q-;$9B<>55C4E*!0HO9;+>J66\`)EG_@X>V*X&C9!S9:S<V<
M#'"ZIA)R6=?P=U[3CM>>VX.40*80M-@\U=@VA>+/E">>7;<3.@RN[=D^\L`C
MQEFM)I4=5N.[=17E,F-?")N2H(/RU:,GXO\`8_.&*=UF$_A^R80S-GO7:H8T
M99'RWN_,;1RV1)ZBWZNW2&J$E\/38A"K4/X2M"P2>.5'+U-)Y[8I%1*<#747
MF7Q[9-UV62#+CS=FP-PDF,,&VKA+$LL3QM(+R,7EN^LJ`%NM]5R+>AD1HR6(
M**U[!;6O^&LDTO3'>;(>P%*S%D_`&&L&05+\:^5M.XVJ4G,$;<!6NLLQ>-:S
M(*MF-8AV$)"3#ET(II(+/BQ[4"`JL=03%+C\SF/"=OV&;9]MS\S.GFY'!GEY
M,<Q_9J07%R[%F4#J2%UM>R@=:\F:%8RBDL3(&[*LK$WCHW4UH;>,_.U5Q=BK
M.63M2]<L@8`REK]/9.85)HT<W*U6.PLL@8TR/)P4Q6QFVB4P#=T*S9$YD2$*
M03=QA3O=V\P^'<E?DFQY63E8.V;KN,65#E+"9"1&B(8IH5=7TG3=;,>O4VMU
M^M/#)XB$E59@0;?014E9O3_:S*&V&N>R=FQ'B/%#"M:7[28DR%0Z+>F4E$4_
M).6YJW/:A#PJB<)$EL:+YK+-UY>42001&16<*`02B`C&X.7<6VSBNX<<QLK+
MRGDWG"GBEDB*M)#`J"1F&IM%BI$:$DZ`HO5,2QK&T8)/?!!/J%8.PUXP-BZ%
MC+PQ0S^E8U8733#,^0;GL;(1MDB!<(UVRR$XYCU(.7;QJ3BYN54W385$NI!*
M)`ZB/8',UO'F7Q[.W/F,T<V2V'O&'%'B!D:VI`H.I2UHP+&QZ_37M\E&:4W-
MG`M6$\5>)G9G&,]7L.7S$T]G;&U+VN0SQ0LPQ^\<_C+&$*DK?4+0A?9[6PE,
MDYA?*L%&N79%S,GP(RC@W:=P5,3'/FMT\U.-[GCR;Q@Y4>#N4VU'%EQSMJ33
M-]D4,2YGB!1`Y"VU+=!U"WL![;)C8:E(5BEB--SV=E[]E=-M!E\ARX7/]85.
MAJ>,;?K)$T@(>S_:;[48\9&:!6+C*B$;&_9^9G"J+"O%_GQ:>V7\\?N].;<Z
M+`B,/W"9Y@V.C2:DT:)3?7&O>;6J]+/TU?O16/(46TF_2K_Y8UYIQ2G%*<4I
MQ2G%*<4IQ2G%*<4IQ2G%*^BGZ,_Y'Y!OTGZ/Z!_+_P"!^/\`<X';2J5`_P`E
MMOY'^EQ_(/\`)?\`&%?XM^[_`.\_RG=RI-^M/UO^=];L';_=V6I58Y3I3BE.
M*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI5*F_Y*>?R5^C#^6_Y*_++_'/
M\G_O].>XOUB_6[?R>WY*^CMKWM_T"/Z']"E_%_T'Y`?H?\C_`(O_``>>#]8^
?_P"7Y:^5^W%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4K_V3\_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
